MAINTENANCE OF VASCULAR ENDOTHELIAL CELL-SPECIFIC PROPERTIES AFTER IMMORTALIZATION WITH AN AMPHOTROPHIC REPLICATION-DEFICIENT RETROVIRUS CONTAINING HUMAN PAPILLOMA-VIRUS-16 E6 E7 DNA/
R. Fontijn et al., MAINTENANCE OF VASCULAR ENDOTHELIAL CELL-SPECIFIC PROPERTIES AFTER IMMORTALIZATION WITH AN AMPHOTROPHIC REPLICATION-DEFICIENT RETROVIRUS CONTAINING HUMAN PAPILLOMA-VIRUS-16 E6 E7 DNA/, Experimental cell research, 216(1), 1995, pp. 199-207
Primary human vascular endothelial cells were immortalized by the inte
gration of a single DNA copy of an amphotrophic, replication-deficient
retrovirus containing the E6/E7 genes of human papilloma virus. To da
te, the resulting cell lines, designated EC-RF7 and EC-RF24, have been
cultured for more than 1 year. The cell lines have retained a diploid
karyotype, display no abnormalities, and are able to grow in a polar
mode. Analysis of the EC-RF cell lines by indirect immunofluorescence,
using an extensive panel of monoclonal antibodies, showed expression
of endothelial cell-specific soluble (von Willebrand factor) and surfa
ce-bound antigens (endoglin, PCAM-1) indistinguishable from that of pr
imary cells. In addition, the expression of the markers CD9, 13, 14, 2
9, 36, 40, 51, and 55 that are not restricted to endothelial cells was
also similar for the immortalized and the primary endothelial cells.
Immortalization did not alter the expression of the surface adhesion m
olecules E-selectin, VCAM-1, and ICAM-1 nor transmigration of neutroph
ils. The regulation of extracellular proteolytic activity by EC-RF24 w
as established by measuring both the induction of functional tissue fa
ctor (promotion of Factor Xa generation) and the functional deposition
of plasminogen activator inhibitor 1 in the subendothelial matrix (SD
S-resistant complex formation with thrombin). Finally, the biosynthesi
s of the endothelial cell-specific von Willebrand factor was studied i
n detail in the EC-RF24 cell line and the results were compared with t
hose of primary endothelial cells. (C) 1995 Academic Press, Inc.